Related by context. All words. (Click for frequent words.) 72 symbol TTH 71 symbol TTHI 70 Amgen Neulasta ® 69 related CMV Retinitis 68 Albuferon albinterferon alfa 2b 68 Crofelemer budesonide foam 67 regenerative therapies E1 INT 67 Completes Patient Enrollment 67 Pruvel TM 67 Amgen Neulasta R 67 Shows Promise Against 67 include Healive TM 67 XL# anticancer compounds 66 patients coinfected 66 Submits Biologics License Application 66 LymphoStat B belimumab 66 evaluating picoplatin 66 Aeolus Pharmaceuticals Announces 66 systemic invasive fungal 66 Vaccine Protects Against 66 AVI BioPharma Announces 66 Tramiprosate ALZHEMED TM 65 novel orally inhaled 65 Initiates Clinical Trial 65 ATRA IV 65 pralatrexate injection folate analogue 65 cladribine Cladribine Tablets 65 VEGFR2 inhibitor 65 CIMZIA r certolizumab pegol 65 JAK2 Inhibitor 65 estrogen receptor beta agonist 65 FDA Approves Generic 65 TRIOLEX HE# APOPTONE HE# 65 Treatment Shows Promise 65 Peginterferon alfa 2b 65 CG# oncolytic virus 65 follicular Non Hodgkin 65 humanized therapeutic 65 rheumatoid arthritis inflammatory bowel 65 Vitrasert ® 65 Initiates Enrollment 65 Begins Dosing 65 ® bortezomib 65 leukemia lymphoma multiple myeloma 65 refractory chronic lymphocytic 65 Bilive TM combined 65 treat hyperproliferative disorders 65 Vaccine Shows Promise 65 Panflu TM Sinovac 65 LymphoStat B TM 65 Vitrasert R 64 non porcine pancreatic 64 Hsp# Inhibitor 64 Telik Announces 64 SILENOR TM doxepin HCl 64 rotavirus shingles 64 approved incretin mimetic 64 progressive metastatic prostate 64 Amigal TM 64 Provectus Pharmaceuticals specializes 64 AAG geldanamycin analog 64 lintuzumab SGN 64 Plicera TM 64 CD# antibody [002] 64 IMiDs ® 64 Albuferon TM 64 Budesonide foam crofelemer 64 Drug Shows Promise 64 TLR7 agonist 64 CYT# potent vascular disrupting 64 TELINTRA R 63 CYP#A# isoenzyme 63 triggers apoptosis programmed 63 pneumocystis pneumonia PCP 63 CDK cyclin dependent 63 Phase 2a Trial 63 novel emulsion formulation 63 neuropathic pain spasticity 63 PEGylated docetaxel 63 Vertex hepatitis C 63 Viread tenofovir disoproxil fumarate 63 Granted Orphan Drug 63 Ribavirin causes 63 Submits NDA 63 Submits Response 63 Investigational Oral 63 Initiates Dosing 63 Demonstrates Potential 63 Entry Inhibitor 63 investigational oral hepatitis C 63 SPRYCEL ® 63 DIFICID ™ 63 MAb therapy 63 deCODE ProstateCancer TM 63 Therapeutic Vaccine 63 Study Shows Promise 63 recurrent metastatic ovarian cancer 63 hematological cancers notably 63 lymphoma multiple myeloma 63 oral prodrug 63 INSPIRE Trial Phase III 63 Associated Adipose Redistribution 63 Slows Progression 63 TRACON Pharmaceuticals 63 Advanced Melanoma 63 combining voreloxin 63 AN# topical anti 63 Initiates Phase III 63 Multiple Sclerosis Rheumatoid Arthritis 63 Receives Fast Track 63 R sorafenib tablets 63 Investigational Treatment 63 Telik logo TELINTRA 63 anti PlGF 63 oropharyngeal candidiasis OPC 63 FDA Approves Drug 62 Bayer HealthCare Onyx Pharmaceuticals 62 sapacitabine CYC# 62 FDA Approves Novel 62 NS5b 62 Vaccine Candidate 62 pneumocystis carinii pneumonia 62 radiation chemoradiation 62 palonosetron hydrochloride Injection Dacogen 62 topical gel formulation 62 Vicriviroc 62 Pegloticase 62 Fast Track Status 62 elderly myelodysplastic syndromes 62 alfa 2a 62 collagen vascular 62 Combination REOLYSIN R 62 toenail onychomycosis 62 dimebon latrepirdine 62 infectious diseases autoimmune diseases 62 COPEGUS R 62 Treatment Reduces 62 inflammatory PDE 62 please visit http:/www.vandapharma.com 62 cause mesothelioma asbestosis 62 e antigen HBeAg 62 Integrase Inhibitor 62 Romidepsin 62 PRN FDA Approves 62 candidates Azedra TM 62 recombinant PSMA vaccine 62 Paliperidone Palmitate 62 FDA Accepts 62 asthma rheumatoid arthritis 62 apricitabine ATC 62 MKC# MT 62 CCR5 mAb 62 paclitaxel Taxol R 62 novel therapeutic antibodies 62 antiangiogenesis therapies 62 Achieves Primary Endpoint 62 induced mucositis 62 AKT inhibitor 62 NASH Huntington 62 Initiate Phase III 62 mitoxantrone plus 62 oral nucleoside analogue 62 Receives Orphan Drug Designation 62 dyslipidemia hypertension diabetes 61 treat musculoskeletal metabolic 61 Vaccine Prevents 61 MEK Inhibitor 61 Treatment Naive Patients 61 castration resistant hormone refractory 61 CNW Transition Therapeutics 61 HIV coinfected 61 Meets Primary Endpoint 61 Oral Laquinimod 61 atherosclerosis rheumatoid arthritis 61 FOLFOX6 chemotherapy regimen 61 Ph + acute lymphoblastic 61 4SC AG ISIN DE# 61 carcinoma mCRC 61 depressive episodes associated 61 please visit www.abraxane.com 61 Atripla combines 61 trastuzumab Herceptin R 61 Submits Supplemental 61 IMPDH inhibitor 61 read Palintologist 61 Clostridium Difficile Associated 61 Demonstrates Positive 61 essential thrombocythemia ET 61 naloxol derivative 61 cystic fibrosis inflammation autoimmune 61 Panzem R 61 MCSP respectively 61 FDA Okays 61 Receives Approvable Letter 61 Newly Diagnosed Chronic Myeloid 61 phase III isavuconazole 61 Dementia Related Psychosis 61 Shows Efficacy 61 HIVMA promotes quality 61 novel synthetic PEGylated 61 memantine HCl 61 Mg Usa 61 HGS ETR1 mapatumumab 61 Biogen Genentech 61 neuromuscular spasm 61 Transition Therapeutics Announces 61 Acute Exacerbations 61 vaginal candidiasis 61 Sodium oxybate 61 Presents Preclinical Data 61 Desvenlafaxine Succinate 61 Drug Candidate 61 NASDAQ TTHI TSX TTH 61 TransVax 61 cytomegalovirus CMV retinitis 61 Relapsed Refractory 61 dasatinib Sprycel ® 61 evaluating tivozanib 61 ® decitabine 61 Files IND 61 Associated Diarrhea 61 Therapy Improves 61 unique alkylating agent 61 sarcoma melanoma 61 investigational integrase inhibitor 61 particularly SANCTURA XR 61 Personalized Immunotherapy 61 Sangamo BioSciences Announces 61 cytidine nucleoside analog 61 basal cell carcinoma squamous 61 involuntary dyskinetic movements 61 Phase 2b Clinical Trial 61 accumulate preferentially 61 Bilive R combined 61 ® lenalidomide 61 Prednisone Against Refractory 60 Phase 2b Trial 60 Naive Patients 60 oral picoplatin 60 relapsed leukemia 60 taxane chemotherapy administered 60 combines bupropion 60 Improves Outcomes 60 chronic progressive neurodegenerative 60 Zenvia ™ 60 bone marrow reticulin deposition 60 TNFerade ™ 60 M# rationally 60 sores onychomycosis nail 60 included exfoliative dermatitis 60 inflammation autoimmune diseases 60 doxepin HCl 60 CYP#A# substrate 60 Anflu R influenza 60 please visit http:/www.avastin.com 60 Patients Treated With 60 Initiate Clinical Trial 60 chemosensitizer 60 VANTAS ® 60 novel VDA molecule 60 Aztreonam lysine 60 Demonstrates Efficacy 60 stage chemoresistant ovarian 60 forodesine 60 Begin Clinical Trials 60 gastrointestinal stromal 60 Cancer AACR NCI 60 epilepsy neuropathic pain 60 advanced metastatic renal 60 acute mania 60 sulfonylurea glimepiride 60 forodesine hydrochloride 60 PRNewswire FirstCall Transition Therapeutics 60 RNAi Therapeutic 60 Phase Ib IIa 60 via intradermal injections 60 Demonstrates Sustained 60 Healthbeat Report 60 Presents Positive 60 Launches Generic Version 60 Second Pivotal Phase 60 gemifloxacin mesylate tablets fluoroquinolone 60 Sapacitabine 60 FUSILEV enhances 60 Thiovir 60 5 fluorouracil leucovorin 60 Prostate Cancer Vaccine 60 Brentuximab Vedotin SGN 60 ASONEP TM 60 GRNOPC1 contains 60 HCV Protease Inhibitor 60 Receives Orphan Drug 60 demonstrated antitumor activity 60 chemotherapy molecularly targeted 60 vaccine RiVax TM 60 metastatic carcinoid 60 opioid tolerant adult 60 metastatic colorectal carcinoma 60 de novo kidney transplant 60 plus prednisone prednisolone 60 Lymphocytic 60 KRYSTEXXA TM pegloticase 60 Test Detects 60 corticotropin injection 60 Gene Mutation Linked 60 resistant hormone refractory 60 Humanized Anti 60 RANK Ligand inhibitor 60 tuberculosis strep throat 60 maximally tolerated lipid lowering 60 Adjuvant Treatment 60 Mg Uk 60 kidney urologic 60 Acute Attacks 60 HBV HCV 60 CDAD Clostridium difficile 59 Synta Announces 59 Novel Oral 59 multiple sclerosis psoriasis 59 dextromethorphan quinidine 59 PDL BioPharma Announces 59 Our BOOSTCAP R 59 Phase IIb Clinical Trial 59 Boxed Warnings 59 Demonstrates Significant 59 Refractory Hodgkin Lymphoma 59 known dihydropyrimidine dehydrogenase 59 HCV polymerase 59 Drug Combo 59 Racivir 59 Nasdaq TTHI 59 substantially excreted 59 itraconazole Sporanox 59 Parlay Entertainment Announces 59 Research www. elsevier.com 59 Announces Tentative Approval 59 genital human papillomavirus 59 Trial Evaluating 59 Constance Lavender 59 bladder ovarian 59 targeted radiotherapeutic 59 MULLIGAN FAMILY FUN CENTER 59 Syndrome HARS 59 MyVax R 59 3 registrational trial 59 CCR5 receptor antagonist 59 receiving opioid analgesics 59 Prolongs Survival 59 Node Positive 59 Onyx Pharmaceuticals Announces 59 Hypertensive adverse reactions 59 Phase IIb Trial 59 Dose Escalation 59 receiving XGEVA 59 Zemiva TM 59 multiple sclerosis Crohn disease 59 tumor angiogenesis inhibitors 59 humanized interleukin 6 59 candidate SMaRT Replacement 59 Videx Videx EC 59 vascular occlusive diseases 59 Slow Progression 59 developing Bicifadine serotonin 59 YOUR LOCAL ANIMAL SHELTER 59 Pharmacokinetics PK 59 TRIOLEX ™ 59 acetonide FA 59 personalized cellular immunotherapy 59 reduce serum phosphate 59 Exelixis compounds 59 Therapy Shows Promise 59 BENLYSTA TM 59 Geokinetics Announces 59 5 HT2A inverse 59 Forodesine 59 oral flupirtine 59 Gabapentin GR TM 59 MOVIPREP R 59 purine nucleoside phosphorylase PNP 59 thetreatment 59 migraine headaches neuropathic pain 59 ® adefovir dipivoxil 59 using VIAdel TM 59 TSX TTH 59 Hormone Refractory Prostate Cancer 59 Kit CD# positive 59 including eniluracil ADH 59 metastatic ocular 59 Phase IIa Clinical Trial 59 pafuramidine maleate 59 R bortezomib 59 CCR9 antagonist 59 Taro Receives 59 including acne photodamage 59 Teva Provides Update 59 INTEGRILIN R eptifibatide Injection 59 Zidovudine Tablets 59 Malignant Glioma 59 Curis collaborator Genentech 59 Cutaneous T 59 nilotinib Tasigna ® 59 Reduces Mortality 59 virus HCV 59 Patients Receiving 59 PORxin TM platforms 59 acute peptic ulcer 59 osteoporosis metabolic disorders 59 Empatic TM 59 R rilonacept Injection 59 Commonly prescribed 59 interferon alpha IFN 59 Pneumocystis pneumonia PCP 59 milnacipran HCl 59 Inc. Nasdaq SGXP 59 R lenalidomide 59 prokinetic agent 59 Treatment Naïve 59 Sleep Disturbances 59 Renal Impairment 59 Interferon beta 1a 59 sorafenib tablets 59 gets USFDA nod 59 Disease Modifying 59 BY DANNY GALLAGHER 58 Archexin 58 acyclovir Lauriad R 58 SinuNase TM 58 GLOBE NEWSWIRE Transition Therapeutics 58 Newly Diagnosed Patients 58 Pafuramidine 58 cortisol synthesis 58 Dean Koontz Bantam FP 58 opioid naive 58 Daclizumab 58 neovascular wet age 58 interferon alpha IFN alpha 58 vapreotide acetate 58 Temsirolimus 58 psoriasis rheumatoid arthritis 58 Levels Linked 58 hormone LHRH antagonist 58 Polymerase Inhibitor 58 Darinaparsin 58 myocardial infarction ventricular fibrillation 58 highly purified pasteurized 58 SNT-MC#/idebenone 58 MVA HPV IL2 58 LJR Recapture Services 58 CNS Disorders 58 irinotecan containing 58 hypoxia activated prodrug 58 specifically hypoactive sexual 58 intravesical infusion therapy 58 Tezampanel 58 Carboplatin Paclitaxel 58 EVIZON TM squalamine lactate 58 myelodysplastic myeloproliferative diseases 58 syndrome gastroesophageal reflux 58 Dacetuzumab 58 refractory myeloma 58 Treatment Experienced 58 pipeline ImmunoGen collaborators 58 anthracyclines taxanes 58 Submits IND 58 next generation URAT1 58 Dendreon investigational 58 ASONEP ™ 58 Genital HPV 58 Barr Receives Approval 58 Lupus Drug 58 R memantine HCl 58 psoriasis Crohn disease 58 oral beclomethasone dipropionate 58 liver cirrhosis liver 58 Fortical ® Unigene nasal 58 GERD migraine headaches 58 Temodar ® 58 Somatuline Depot 58 Lowers Risk 58 inflammatory autoimmune diseases 58 treats paroxysmal nocturnal 58 erlotinib Tarceva ® 58 Complicated Skin 58 Study Evaluating 58 Gout Drug 58 include Phenoptin TM 58 Vidaza ® 58 anticancer antiviral 58 Maribavir 58 doxepin hydrochloride 58 Testosterone MDTS R 58 Enlarged Prostate 58 induced macular edema 58 NPS Pharmaceuticals Announces 58 BCG refractory carcinoma 58 Recombinant interferon alpha 58 Alzheimer disease cognitive impairment 58 Merck Suspends Lobbying 58 Xcytrin R 58 delivers fluocinolone acetonide FA 58 CYP#A# CYP#D# 58 hypereosinophilic syndrome 58 Successfully Treats 58 postherpetic neuralgia PHN 58 Orally Active 58 Shows Statistically Significant 58 Antiviral Drug 58 Sustiva efavirenz 58 agents Tabun Sarin 58 interferon beta 1a infertility 58 radiation enteritis 58 Glufosfamide 58 Cerebril TM 58 Panzem R NCD 58 allosteric modulator PAM 58 biologic antibody 58 Senetek PLC Announces 58 Omacetaxine 58 onychomycosis psoriasis acne 58 RhuDex TM 58 Momenta Pharmaceuticals Announces 58 Nicotine Vaccine 58 endocrinology orthopedics kidney 58 Tibotec Therapeutics division 58 Drug Resistant 58 post herpetic 58 enzymatically activated within 58 By JENNIFER LEARN 58 rheumatoid arthritis thrombocytopenia 58 Valopicitabine 58 Ragweed Allergy 58 AirBoss Announces 58 Pre Exposure Prophylaxis 58 infliximab monotherapy 58 commercialize deforolimus 58 Boxed WARNINGS 58 See CLINICAL PHARMACOLOGY 58 gastrointestinal mucositis 58 HBeAg + 58 ovarian esophageal 58 Opportunistic infections 58 Combivir Kivexa 58 relapsed MM 58 Cell Non Hodgkin 58 Adenoviral 58 www.soliris.net 58 trauma malignant tumors 58 Often Misdiagnosed 58 torsemide ER 58 Nat Rev 58 unresectable recurrent 58 PF # [002] 58 Romiplostim 57 treatment naive genotype 57 telaprevir VX 57 alpha1 antitrypsin deficiency 57 R Bortezomib 57 Rheumatoid Arthritis Drug 57 Acute Intermittent Porphyria 57 Aztreonam Lysine 57 orally administered synthetic retinoid 57 Inhibitex Reports 57 Bosutinib 57 either acutely decompensated 57 infection epistaxis dyspnea exfoliative 57 Talabostat 57 post herpetic neuralgia PHN 57 hyperphenylalaninemia HPA due 57 SIMPONI TM 57 Lupus Nephritis 57 previously untreated follicular 57 DEB# 57 Antitumor Activity 57 treat chronic sinusitis 57 pegylated interferon peg IFN 57 sleeping sickness trypanosomiasis 57 Relapsed Refractory Multiple Myeloma 57 Physician Insights 57 NICE Recommends 57 Voreloxin 57 Panzem ® 57 multiple sclerosis amyotrophic lateral 57 hyperplasia BPH 57 autoimmune disorders asthma 57 Golimumab 57 brand ciclesonide HFA 57 HDAC Inhibitor 57 BY RYAN BENTLEY 57 multiple sclerosis fibromyalgia 57 cadmium cobalt 57 NMT Medical Announces 57 Pandemic Influenza Vaccine 57 Infected Patients 57 factors VIIa 57 Pharmacyclics Announces 57 Oral Fingolimod 57 Perifosine KRX 57 SUTENT ® 57 patients receiving myelosuppressive 57 5q MDS 57 Salix Pharmaceuticals Announces 57 nucleotide analog 57 Clot Busting 57 ZANAFLEX CAPSULES ® tizanidine 57 Collaborators Present 57 Improves Survival 57 vaccine RiVax ™ 57 Reveals Positive 57 commercialized DURECT 57 COLAZAL R 57 KRN# 57 Capsules CII 57 Showed Significant 57 hereditary emphysema 57 Allion Healthcare sells 57 Bayer Nexavar 57 anaphylactic reactions bronchospasm 57 Potent Antiviral Activity 57 hepatocellular carcinoma liver 57 includes TOLAMBA TM 57 bacillus Calmette Guerin BCG 57 cytomegalovirus retinitis 57 lead molecular radiotherapeutic 57 rash pruritus nausea 57 Ecallantide 57 Retisert ® 57 virologically suppressed 57 Randomized Double blind 57 IMiDs ® compound 57 Safinamide 57 antiretroviral naïve 57 Demonstrate Significant 57 HIV treatments Reyataz 57 Appears Safe 57 prednisone prednisolone plus 57 Pfizer Camptosar 57 Clinical Trial Results 57 Improved Progression 57 headache abdominal pain 57 decompensated liver disease 57 GW# [003] 57 adalimumab Humira 57 thiazolides 57 Testosterone MDTS ® 57 Phase 1b clinical trials 57 Aethlon Medical Announces 57 Boehringer Ingelheim MedImmune 57 5 FU leucovorin 57 metastatic pancreatic 57 Carbidopa Levodopa 57 Vaginal gel 57 Schizophrenia Drug 57 ViroChem 57 Newly Diagnosed Multiple Myeloma 57 Pandemic Flu Vaccine 57 Systemic Sclerosis 57 aMCI precursor 57 headache tiredness dizziness 57 hepatitis B HBV 57 myelofibrosis polycythemia vera 57 clinical trials SGN 57 Minera IRL Announces 57 rasagiline tablets 57 relapsing remitting MS RRMS 57 An Opportunity Awaits 57 CD# CEA 57 neutropenia dehydration dyspnea 57 Antigen Specific 57 drug figitumumab 57 naïve HCV 57 leukemia APL 57 Immunosuppressant 57 PrevOnco 57 Tyrosine Kinase Inhibitor 57 TNF Blockers 57 Relapsed Multiple Myeloma 57 concurrent ITP 57 generation purine nucleoside 57 Genes Predict 57 Preclinical Data 57 relapsed acute lymphoblastic 57 gemcitabine Gemzar ® 57 Vaccine Trial 57 Eculizumab 57 Tenofovir Disoproxil Fumarate 57 steroid refractory ulcerative 57 adhesion molecule EpCAM expressing 57 selective modulator 57 discontinued Viread 57 5 lipoxygenase inhibitor 57 severe hypercholesterolemia 57 Muraglitazar 57 irinotecan doxorubicin oxaliplatin paclitaxel 57 lymphoma leukemia 57 Elotuzumab 56 UGI Declares 56 Receives CE Marking 56 PEGylated Fab fragment 56 cyclophosphamide chemotherapy 56 lexidronam injection 56 Selzentry maraviroc 56 Altera Nebulizer System 56 Sitebrand Announces 56 cisplatin gemcitabine 56 ARIXTRA R 56 proprietary intravenous formulation 56 ISTODAX ® 56 Vaccine Immunology 56 delivers preprogrammed intermittent 56 treatment naïve genotype 56 Immunomedics Announces 56 combines Zetia 56 Abbott Laboratories Kaletra 56 Peginterferon 56 POSIDUR TM ELADUR TM 56 BARACLUDE R 56 liver colon rectal 56 BioMarin filings 56 unresectable tumors 56 hepatitis B immune globulin 56 including cyclosporine methotrexate 56 Gamunex C 56 Enzastaurin 56 MetroGel 56 drug Treanda 56 Previously Treated 56 Plaque Psoriasis 56 Patient Treated 56 R Saizen R 56 Vildagliptin 56 Zenvia TM 56 Psoriasis Drug 56 Kinase Inhibitor 56 investigating Serdaxin 56 nucleotide analogue 56 Picture Jono Searle 56 recurrent glioblastoma multiforme 56 endometrial breast 56 erlotinib Tarceva R 56 By BRENDAN KIRBY 56 polysaccharide polymer 56 Carbidopa 56 diagnostic molecular imaging 56 Frozen Shoulder syndrome Adhesive 56 emulsion formulations 56 docetaxel Injection Concentrate 56 Shiwakoti wrinkled 56 hypertrichosis occurred 56 humanised monoclonal antibody 56 Enbrel rheumatoid arthritis 56 Shows Promising 56 zileuton injection 56 candidate SUVN 56 sNDAs 56 lamivudine zidovudine 56 hoFH 56 Single Dose 56 asthenia weakness 56 Acute Radiation Syndrome 56 uterine fibroids endometriosis 56 Relapsing Multiple Sclerosis 56 J Antimicrob Chemother 56 concomitant cardiac 56 Nipent R 56 dihydroergotamine mesylate DHE 56 vomiting anorexia stomatitis 56 Diabetic Foot Ulcer 56 candidate SILENOR TM 56 Chemotherapy Improves 56 nephropathic cystinosis 56 HER2 Positive Breast Cancer 56 EOquin TM phase 56 Study Tanning beds 56 Anthracycline 56 Systemic lupus erythematosus SLE 56 Intravitreal 56 HP Acthar Gel repository 56 Completes Enrollment 56 PEGylated interferon 56 Tesmilifene 56 CTAP# Capsules 56 Truvada Viread 56 PLX STROKE targeting 56 R pramlintide acetate 56 TO AVOID PREGNANCY WHILE 56 novel L DOS# 56 Progressive Multifocal Leukoencephalopathy 56 refractory metastatic 56 non resectable metastatic 56 SYN# 56 pegylated interferon alfa 2a 56 RAS MAPK pathway 56 R eptifibatide Injection 56 Gene Linked 56 measles mumps chickenpox diphtheria 56 treat atopic dermatitis 56 PEGINTRON TM 56 8mg/kg 56 R pegaptanib sodium 56 indications Dupuytren 56 HQK 56 Diamyd r 56 autoimmune uveitis 56 Present Preclinical Data 56 vitreoretinal disorders 56 selective inverse agonist 56 Combo Therapy 56 Edurant 56 TNF Tumor Necrosis Factor 56 Adjunctive Therapy 56 investigational monoclonal antibody 56 Melphalan 56 Namenda Memantine HCl 56 Aurora Kinase 56 null responder HCV 56 non constipating irritable 56 Epratuzumab 56 pegylated interferon alpha 2a 56 Nuvelo Announces 56 FOLFOX chemotherapy 56 Vasogen Announces 56 Relapsed Refractory Aggressive 56 Carcinoid Syndrome 56 containing LABAs 56 Combination Treatment 56 candidates Azedra 56 chronic lymphocytic 56 uterine fibroid induced 55 dasatinib Sprycel 55 epilepsy multiple sclerosis 55 exocrine pancreatic insufficiency EPI 55 Simulect 55 Symbollon Pharmaceuticals Announces 55 Peginterferon Alfa 2a 55 FORADIL 55 Investigational Drug 55 Epstein Barr Virus EBV 55 mild vasodilator 55 stage IIIb IV 55 Pegasys peginterferon alfa 2a 55 antibody MAb 55 INFECTED WITH 55 Ovitrelle R Serostim 55 Ltd. Teva Neuroscience 55 metastatic colorectal 55 carcinoid syndrome diabetes 55 Blood Pressure Drug 55 AFREZZA ™ 55 STELARA ® 55 angiotensin analog 55 tuberculosis hepatitis B 55 Leukopenia neutropenia 55 fatigue abdominal pain 55 epilepsy Parkinson disease 55 Hepatitis B HBV 55 valtorcitabine 55 Corcept Therapeutics Announces 55 Postmenopausal Osteoporosis 55 hypertension osteoarthritis 55 Chronic Hepatitis C 55 Lung Cancer Vaccine 55 BRAF V# mutation 55 Campath alemtuzumab 55 ® natalizumab 55 Mouse Model 55 www.BYETTA.com 55 receiving VELCADE 55 BRAF gene mutations 55 Spectrum Pharmaceuticals Announces 55 psychiatric disorders ATI 55 COPEGUS ribavirin 55 Demonstrates Potent 55 5 HT2A serotonin 55 Pazopanib 55 Pegintron 55 Aryplase 55 Previously Untreated 55 drug resistant Acinetobacter 55 PEG INTRON R 55 Accelrys Announces 55 Pivotal Phase III 55 Relieves Pain 55 Metastatic Melanoma 55 VYVANSE TM lisdexamfetamine 55 www.telik.com 55 lenalidomide Revlimid R 55 mGluR2 positive 55 Farrah Fawcett dies 55 baminercept 55 oral proteasome inhibitor 55 TTR amyloidosis 55 BRAF mutant 55 receptor tyrosine kinase inhibitor 55 REBETOL combination 55 orally disintegrating formulation 55 induced anemia 55 Aflibercept 55 non polyposis colorectal 55 Bezielle 55 pyrimidine nucleoside analog 55 ropinirole Requip 55 vinorelbine tartrate 55 galiximab 55 neuro inflammatory 55 Gel repository corticotropin injection 55 Soluble CD# 55 FOR FURTHER INFORMATION ABOUT 55 Anal Cancer 55 rheumatoid arthritis RA psoriatic 55 polyneuropathy HIV DSP 55 novel nucleoside analog 55 Regenerative Cell 55 By MICHAEL RADANO 55 Long acting beta2 55 lymphoid cancers 55 ® Isch Dish 55 Repligen Reports 55 MKC# MKC# PP 55 Renal Cancer 55 CTAP# Injection 55 pancreatic prostate 55 LHRH receptor positive 55 VELCADE novel 55 Poorly Controlled 55 Hepatitis C Virus HCV 55 Myelofibrosis 55 SANCTURA XR NEBIDO 55 Zorbtive TM 55 Phase 2a Clinical Trial 55 Interferon alfa 2b 55 transcriptase inhibitor NNRTI 55 Rotavirus Vaccines 55 Elagolix 55 Gets FDA Clearance 55 Peginterferon Alfa 2b 55 Oropharyngeal Candidiasis 55 chagas disease 55 Cojocaru correspondent 55 Chlamydia gonorrhea 55 Hepatitis Virus 55 R Isch Dish 55 MAXY alpha 55 Renal Cell Cancer 55 therapies ACTs 55 Seliciclib 55 Multiple Myeloma Patients 55 Interferon Ribavirin 55 FDA Clears 55 Arzerra ofatumumab 55 Novolimus 55 STAR WARS ARCHIVES EPISODES 55 Preclinical Models 55 OncoVex 55 Demonstrated Significant 55 Varicella Zoster 55 investigational protease inhibitor 55 Leukemias 55 Genes Identified 55 RhuDex ® 55 Circumcision reduces 55 endocrinology gastroenterology 55 inflammation metabolic disorders 55 headache nasopharyngitis 55 Invasive pneumococcal disease 55 Etravirine 55 cyclophosphamide doxorubicin vincristine 55 Fludarabine 55 orBec R oral beclomethasone 55 include ELND# AZD 55 Atacicept 55 Resistant Hypertension 55 Tykerb lapatinib 55 Eszopiclone 55 haemophilus influenza B 55 Antidepressants Linked 55 Relapsing Remitting Multiple Sclerosis 55 Hepatitis C HCV 55 Soft Tissue Sarcoma 55 Neovascular Age Related Macular 55 receiving immunosuppressive therapy 55 Anti Tumor Activity 55 Enzo Biochem Reports 55 non nucleoside HCV 55 Insegia 55 prednisone CHOP 55 MEDICAL ATTENTION 55 Neugene 55 balsalazide disodium Capsules 55 mitogen activated ERK kinase 55 orBec ® oral beclomethasone 55 oral antiviral 55 Experimental Vaccine 55 severe hepatic dysfunction 55 STELARA TM 54 Severe Sepsis 54 reliever tramadol 54 multiple sclerosis muscular dystrophy 54 Soy Isoflavones 54 Patients Suffering